Compare Sanofi SA (SNY) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs US Bancorp — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: Sanofi SA and US Bancorp are close in size by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | USB | |
|---|---|---|
Market Cap | $104.83B | $98.36B |
Sector | Health | Financials |
52-Week High | $52.34 | $64.01 |
52-Week Low | $41.33 | $43.94 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
